Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.

Lancet Infect Dis · 2020 · PMC6990395 · PMID 31757774

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The magnitudes of responses in this age group (when combining responses in the five cohorts) were all highly significant and similar for CFA/I, CS3, CS5, and LTB (18–50-times increase), with somewhat lower responses against CS6 (eight-times increase; figure 1A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.